טוען...
Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus
Liraglutide is a glucagon-like peptide 1 (GLP-1) analog indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise in adults. Liraglutide lowers blood glucose levels by stimulating insulin secretion and decreasing glucagon release in glucose-dependent manners, increas...
שמור ב:
Main Authors: | , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Hindawi Publishing Corporation
2013
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3814067/ https://ncbi.nlm.nih.gov/pubmed/24222881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/703925 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|